MoneyWorks4Me

The Revenue for the quarter ended  June 2026 of Rs. 3922.75 millions grew by 18.00 % from Rs. 3324.43 millions.The Net proft of the company remain more or less same to Rs. 448.39  millions from Rs. 448.67 millions ,decline by -0.06%.Operating profit for the quarter ended June 2026 rose to 746.07 millions as compared to 726.63 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3922.75 3324.43 18.00 3922.75 3324.43 18.00 13487.36 13117.84 2.82
Other Income 261.04 285.55 -8.58 261.04 285.55 -8.58 1129.65 1241.92 -9.04
PBIDT 746.07 726.63 2.68 746.07 726.63 2.68 2104.25 2626.91 -19.90
Interest 24.76 29.11 -14.94 24.76 29.11 -14.94 100.38 153.09 -34.43
PBDT 721.31 697.52 3.41 721.31 697.52 3.41 1938.68 2473.82 -21.63
Depreciation 127.95 102.46 24.88 127.95 102.46 24.88 455.03 395.45 15.07
PBT 593.36 595.06 -0.29 593.36 595.06 -0.29 1483.65 2078.37 -28.61
TAX 144.97 146.39 -0.97 144.97 146.39 -0.97 367.25 468.39 -21.59
Deferred Tax -8.53 -15.84 -46.15 -8.53 -15.84 -46.15 -3.69 -7.14 -48.32
PAT 448.39 448.67 -0.06 448.39 448.67 -0.06 1116.40 1609.98 -30.66
Equity 306.21 306.21 0.00 306.21 306.21 0.00 306.21 306.21 0.00
PBIDTM(%) 19.02 21.86 -12.99 19.02 21.86 -12.99 15.60 20.03 -22.09

Akums Drugs & Pharma Share Price

752.40 8.70 (1.17%)
19-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1898.00
Dr. Reddys Labs. 1171.00
Cipla 1416.00
Lupin 2220.00
Zydus Lifesciences 1105.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: